Grandrent himself has several specialized private hospitals, and is no stranger to the operation and operation of hospitals, but these things no longer need him to do it personally, and the world-wide distribution network is not something that can be done in a short period of time, and can only be expanded in a few countries in each state first, of course, the choice must be a country with a large population and large consumption potential, which is in line with the set market strategy, after discussion by the expert group, it was determined that the United Kingdom in Europe, Brazil in the Americas, In Asia, Japan and China are the first to set up laboratories and hospitals, because these countries have a tendency to officially support cloning treatment, and will get a lot of convenience in terms of application and investment in construction.

Through the legal counsel's research on the legislation on cloning in these countries, Smith combined the technology they used, and found that it did not violate the spirit of their law, and that there was no process of generating embryos during the entire organ culture process, and there was no sign of human cloning, which further strengthened Grandrent's determination. The legislation of various countries is mainly to prohibit the emergence of human cloning, rather than fundamentally opposing everything related to cloning, because the former will cause chaos in the entire human society, and personal safety and social order will be unbearable.

"Well, you can find the right time in the future, contact Grandrent, and ask for this market in Africa, which is still very poor, as long as you make a good word, he will not let this place go." Xue Yunchu naturally wants to share more interests in this, and within the scope of what the other party can tolerate, the place in Africa that doesn't seem to have much consumption potential should not be held on.

Jiang Minghong was also moved after hearing the plan leaked by the boss, this is really a huge cake, not much worse than the profits of drugs and arms, and the risk is very small, building a hospital is a kind of charity in the traditional concept, of course, the premise can not be high, in the medical industry for a few years, he also understands how big the profit is, take the current bone marrow transplant as an example, as long as the donor with the same match is found, they are often donated for free, and the patient's medical expenses have not been reduced because of this free source, Generally between 10 and 300,000. In addition to the medical costs of the hospital for radiotherapy, chemotherapy and other conventional treatments, this cost includes a sum of money paid to the database that provides the source of matching, and it is not difficult to calculate the profit in it.

Now the price of organs in the international market to kidney as an example, Belgium openly legislated that it is 40,000 US dollars a piece, to ensure the interests of kidney donors, but many countries are expressly prohibiting this kind of kidney sales, but if the kidney is donated for free, in addition to relatives, there will be no normal people who will risk the decline of their physical condition to do it, and the source can only be donated by relatives of people who died in an accident. Other organs are also included, in short, it is a seller's market.

Jiang Minghong, who has seen the greedy faces of some people, can't help but worry that other countries will ask for this kind of technology in the name of benefiting mankind.

"Grandrent is not a young and impulsive person, the United States has more advanced technology, and I have never seen him provide it to that country for free to reflect his status as a world leader." Xue Yunchu said a word about his concern.

After many contacts with officials and legislators in the Ministry of Health, as well as a series of negotiations with the consortium that manipulated the government's policy orientation, the biomedical technology, which was unlikely to be protected by a patent, has privately reached a clause for the passage of the patent application.

Subsequently, the U.S. government passed two bills in two months. One is the "Filing of Patent Application for Biomedical Technology", which stipulates that some biomedical technologies with huge market potential can be protected by patents, such as gene therapy and regenerative therapy.

The second was the Draft Lifting of the Embargo on Research on Therapeutic Cloning. Provision was made for the legalization of research on therapeutic cloning and the lifting of government restrictions on investment in that area.

The price paid by Grandrent was to provide part of the targeted cultivation of organs, and after the patent application was approved, the U.S. government was allowed to use this technology in various government-led research, and after the patent was successfully passed, all the technical information was provided, and the U.S. government's obligation was to protect the patent from being used by others. Of course, the distribution of interests in it is that Grandrent accounts for the majority. In response, the Ministry of Health official laughed at himself: "It's better than nothing at all." ”

The sudden U-turn of the United States, which has always opposed any form of cloning research, is the most severe blow to the United Nations, which is working to ban cloning research worldwide. However, many universities and research institutions in the United States applaud this so that they can get more government funding and accelerate the pace of research.

Other countries have had mixed reactions to this attitude of the U.S. government, but given that many countries have such precedents, there is little to question them.

Jiang Minghong is in the United States, and he knows a lot about the inside story, so he naturally knows that this is the result of a compromise between the two sides, this Grandrent's foundation is really deep enough, and ordinary people will definitely not be able to achieve such a relative advantage, not to mention that the United States is originally a rich man's politics, and the government will definitely not be able to rely on a strong position to plunder his technology, which will cause a strong backlash from those consortia, because it will violate their fundamental interests, and in his bones Grandrent is also one of them, Grandrent must have been inextricably linked to them.

Thinking of what happened to him, Jiang Minghong couldn't help but sigh slightly, he was alone at the beginning, his situation was in danger, and he couldn't keep his achievements at all, and now he thinks about it, he still has to lay a good foundation first. There are a lot of companies on hand, and they should be regrouped and invested in Africa, all of which need to be done.

After the second bill passed, an article appeared in an American science weekly, about a privately funded laboratory in the United States has made a key breakthrough in the directed cultivation of organs, and the person who presided over this study was Dr. Smith Reitman, a well-known clone research expert in the American medical field.

For the content of this article, Xue Yunchu knew in advance. When Grandrent told him about this plan, Xue Yunchu thought of something else. Although it is said that he is in charge of this research, it is not convenient to let himself take the lead in view of the ulterior nature of the main purpose of the research, so as not to attract too much attention and expose the whole project, so it is a question who will receive this honor. Of course, now that I understand what this kind of honor means to ordinary people, it is natural that I can't give it away for nothing, but I still have to bargain for it.

When Smith came to consult privately on this issue, Xue Yunchu understood what the other party was paying attention to, and it was precisely because this guy was an orthodox scientist that he took these honors very seriously. After taking a general look at his information, Xue Yunchu was ready to sell at the price.

Smith knew that the whole plan was not allowed by today's law, so as the proposal and leader of the whole subject, he could not show up rashly, and this ancillary achievement had such great significance, he was absolutely unwilling to give it to others, and it was best to receive it by himself, although it was a bit of a presumption, but he also had the name of a deputy head in charge, and he was more qualified than others.

After a private discussion with the doctor for half an hour, he readily offered to make himself the inventor of this achievement, of course, not for free, and he paid for the various shares of the company that he had given over the years, which were worth about three or four hundred million dollars.

After making this deal, Smith felt a little painful, but firstly, he had no heirs, and secondly, the money was not taken into account compared to the great significance and scientific honor of the research results. What's more, he hasn't used his own private funds in his research all along, and he doesn't have much use for it anywhere, so it's well worth it to exchange these things.

Only three people knew about this deal, and he, the doctor, and his boss Grandrent, thought that his name would soon be recorded in the history of science with this research. Thinking of this, Smith couldn't stop his excitement, and he actually lost sleep that day.

Naturally, for the other researchers who worked on this research, there would be no less honor for them, and Smith was well aware of this. After all, the whole research program still depends on them to cover up.